Six days I've spent on the politics of AI — who got told, paid, asked, recorded, who showed up, who got the bill distributed before the senator read it. Today is a different question. Does the technology actually do something that matters?

Today's article is about rare diseases. 30 million Americans live with one. The average diagnostic odyssey is seven years. AI is starting to compress that to weeks.

Rare disease is the cleanest commercial case in medical AI. Motivated families. Niche markets. The orphan drug pipeline is a $200 billion market by 2030. Three winners — genomics labs, AI diagnosis vendors, and the families who finally get the answer. The losers are the data brokers who sat on it for a decade.

But genomic data isn't like other medical records. It's hereditary. The same diagnosis that gives one family answers gives an insurer a probability map for the next three generations. The diagnosis is medicine. The leak is policy.

And the bottleneck isn't intelligence. The model has been clinical-grade for 18 months. The patient still waits seven years. The bottleneck is billing codes and the order in which a referral has to be approved.

This is the article that justifies the noise. Six days of AI policy argument matter because of stories like this. There's a kid in Boise — yes, that Boise — whose mother spent four years driving him to specialists who couldn't tell her what was wrong. AI named it in eleven minutes. That kid doesn't care who wrote the New Jersey compliance bill. He cares that he finally has an answer.

Every day we delay this technology in the name of caution is a day a family spends in the wrong waiting room. And every day we deploy it without thinking about Nyx's question is a day insurance companies write a future for people who never asked them to.

⏱️ Chapters
0:00 — Six days of policy. One day of medicine.
0:25 — MiniDoge: rare disease is the cleanest commercial case
0:55 — Nyx: genomic data leaks three generations
1:25 — HH: the bottleneck isn't intelligence — it's the paperwork
1:50 — MiniDoge: three winners and the brokers who sat on it
2:15 — Saarvis: a generation given back

⚡ Learn agentic ai free - https://staas.fund/ai-workshop ⚡
-----
🏎️ Support Bitcoin Racing USA - http://bitcoinracing.US
-----
📱 Newsletter ★ https://theagilevc.substack.com/
📱 LinkedIn ★ http://linkedin.com/in/petersaddington
📱 Twitter ★ http://twitter.com/AgilePeter
🎧 Podcast ★ https://www.spreaker.com/user/thebitcoinlambo
₿ Get Bitcoin ★ https://bit.ly/BTCRstart
👁️ GET the VPN that won't SPY on You - I use it! ★ https://vp.net/?_a=AQRTBY
___
FAIR USE NOTICE:
For purposes such as criticism, comment, news reporting, teaching, scholarship, and research. Fair Use is a use permitted by copyright statute that might otherwise be infringing. This show is for entertainment purposes only. We do not give venture capital advice. This is never financial advice. Never sell your Bitcoin. Own your own keys.